Orsula Knowlton Net Worth

The estimated Net Worth of Orsula V Knowlton is at least $60.6 Million dollars as of 23 December 2021. Orsula Knowlton owns over 20,000 units of Tabula Rasa HealthCare Inc stock worth over $3,843,599 and over the last 8 years he sold TRHC stock worth over $52,903,464. In addition, he makes $3,805,930 as President, Co-Founder, Chief Marketing Officer & New Business Development Officer und Director at Tabula Rasa HealthCare Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Orsula Knowlton TRHC stock SEC Form 4 insiders trading

Orsula has made over 91 trades of the Tabula Rasa HealthCare Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 20,000 units of TRHC stock worth $296,400 on 23 December 2021.

The largest trade he's ever made was exercising 688,279 units of Tabula Rasa HealthCare Inc stock on 26 January 2017 worth over $2,642,991. On average, Orsula trades about 26,308 units every 18 days since 2016. As of 23 December 2021 he still owns at least 366,057 units of Tabula Rasa HealthCare Inc stock.

You can see the complete history of Orsula Knowlton stock trades at the bottom of the page.

Orsula Knowlton biography

Dr. Orsula Voltis Knowlton serves as President, Co-Founder, Chief Marketing Officer & New Business Development Officer, Director of the Company. She has served as President and a director of CareKinesis since May 2009. She previously served in numerous positions, including Vice President and Chief Marketing Officer, and New Business Development and Strategy Officer, of excelleRx, Inc. from April 1995 through July 2007. Dr. Orsula Knowlton currently serves on the Board of Trustees of Samaritan HealthCare and Hospice, a position she has held since 2009, currently serving as Secretary and Chair of the Governance Committee and she is also a member of the Executive Committee and previously chaired the Quality Committee. From 2009 until 2015, Dr. Orsula was a member of the Board of Trustees for the West Jersey Chamber Music Society. Dr. Orsula Knowlton served on the Dean’s Advisory Board, School of Public Health, Drexel University, Philadelphia, PA from 2008 through 2011; the founding Dean’s Advisory Board of Jefferson School of Pharmacy, Philadelphia, PA from 2009 through 2012; the Board of Advisors for the George Washington Institute on Spirituality and Health, Washington, DC from 2009 through 2012; and the Board of Trustees for Family Services, Mt. Holly, NJ (Oaks Integrated Care) from 2009 through 2012. Dr. Orsula Knowlton graduated from the University of the Sciences School of Pharmacy and Temple University’s executive Masters in Business Administration program. Dr. Orsula Knowlton is married to Dr. Calvin Knowlton.

What is the salary of Orsula Knowlton?

As the President, Co-Founder, Chief Marketing Officer & New Business Development Officer und Director of Tabula Rasa HealthCare Inc, the total compensation of Orsula Knowlton at Tabula Rasa HealthCare Inc is $3,805,930. There are 1 executives at Tabula Rasa HealthCare Inc getting paid more, with Calvin Knowlton having the highest compensation of $5,135,730.

How old is Orsula Knowlton?

Orsula Knowlton is 52, he's been the President, Co-Founder, Chief Marketing Officer & New Business Development Officer und Director of Tabula Rasa HealthCare Inc since 2014. There are 14 older and 2 younger executives at Tabula Rasa HealthCare Inc. The oldest executive at Tabula Rasa HealthCare Inc is A. Gordon Tunstall, 76, who is the Lead Independent Director.

What's Orsula Knowlton's mailing address?

Orsula's mailing address filed with the SEC is 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN, NJ, 08057.

Insiders trading at Tabula Rasa HealthCare Inc

Over the last 8 years, insiders at Tabula Rasa HealthCare Inc have traded over $245,667,405 worth of Tabula Rasa HealthCare Inc stock and bought 1,486,398 units worth $7,620,320 . The most active insiders traders include Calvin H Knowlton, Orsula V Knowlton und Capital Management, L.P.Ic .... On average, Tabula Rasa HealthCare Inc executives and independent directors trade stock every 8 days with the average trade being worth of $441,116. The most recent stock trade was executed by Michael Greenhalgh on 28 June 2023, trading 25,000 units of TRHC stock currently worth $77,750.

What does Tabula Rasa HealthCare Inc do?

the tabula rasa healthcare family of companies provide new beginnings for our clients, through innovative service models and fresh approaches to healthcare technology. our leaders understand that to maximize patient experiences and outcomes, they must help providers to balance efficiency and scalability with safety and individualization of care.

Complete history of Orsula Knowlton stock trades at Tabula Rasa HealthCare Inc

Tabula Rasa HealthCare Inc executives and stock owners

Tabula Rasa HealthCare Inc executives and other stock owners filed with the SEC include:

• Calvin Knowlton,
  Chairman of the Board, Chief Executive Officer, Co-Founder
• Orsula Knowlton,
  President, Co-Founder, Chief Marketing Officer & New Business Development Officer, Director
• Brian Adams,
  Chief Financial Officer
• Pamela Schweitzer,
  Independent Director
• Dr. Calvin H. Knowlton BSc Pharm, MDiv, Ph.D.,
  Co-Founder, Chairman & CEO
• A. Gordon Tunstall,
  Lead Independent Director
• Dr. Orsula Voltis Knowlton BScPharm, M.B.A., MBA, Pharm.D., PharmD,
  Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director
• Michael Greenhalgh,
  Chief Operating Officer
• Michael Purcell,
  Independent Director
• Samira Beckwith,
  Independent Director
• Dennis Helling,
  Independent Director
• Jan Berger,
  Independent Director
• Kathrine O'Brien,
  Independent Director
• Frank Sparacino,
  IR Contact Officer
• Jeffrey DiFrancesco,
  Chief Product Officer
• Bob Sullivan,
  Chief Technology Officer
• Steve Lemak,
  Senior Vice President - IT Infrastructure, CareVention HealthCare Division
• Michael Greenhalgh,
  Co-Founder, Chief Operating Officer
• Frank Sparacino C.F.A., CPA,
  Sr. VP of Investor Relations & Corp. Devel.
• Phillip W. Heath MS,
  Chief Admin. Officer
• Dr. Jacques Turgeon B.Pharm., Ph.D.,
  Chief Scientific Officer & CEO of TRHC Precision Pharmacotherapy, R&D Institute
• Joseph J. Filippoli,
  Chief Information Officer
• Bob Sullivan M.S.,
  Chief Technology Officer
• Andrea Carolan Speers M.S.,
  Corp. Controller & Chief Accounting Officer
• Bruce Luehrs,
  Director
• Venture Partners Iii, Llcra...,
  
• Eric R Arnson,
  10% owner
• Growth Fund 1 Q Lpbressner ...,
  
• Daniel C Lubin,
  Director
• Michael J Gausling,
  10% owner
• Glen R Bressner,
  Director
• Growth Fund 1 A Lpbressner ...,
  
• Joann M. Durham,
  10% owner
• John R. Durham,
  10% owner
• Growth Fund 1 A Lp Originat...,
  
• Stage2 Ventures, L.P.Stage2...,
  
• Growth Fund 1 Q Lp Originat...,
  
• Michael Anthony Bruno,
  CHIEF ACCOUNTING OFFICER
• Ronald Paul Mitchell,
  
• Thomas Cancro,
  CHIEF FINANCIAL OFFICER
• Richard W. Ii Rew,
  CHIEF LEGAL OFFICER, SECRETARY
• Jonathan David Schwartz,
  
• Capital Management, L.P.Ic ...,
  
• Capital Management, L.P.Ic ...,
  
• Capital Management, L.P.Ind...,